Back to News

Categories: News | Published On: December 8, 2024 | Written by webadmin@biolojic.com |

Biolojic Design Joins Johnson & Johnson Innovation – JLABS

Back to News
More News
  • Biolojic Design Appoints Neal Curran as Chief Business Officer
    Read More
  • Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
    Read More
BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com